Korean J Lab Med.  2010 Aug;30(4):432-439. 10.3343/kjlm.2010.30.4.432.

Evaluation of a Multiplex PCR Kit Used for Detecting Y Chromosome Microdeletions

Affiliations
  • 1Department of Laboratory Medicine, Pusan National University School of Medicine, Busan, Korea. kwanlee@dongguk.edu
  • 2Department of Medicine, Pusan National University School of Medicine, Busan, Korea.
  • 3Department of Urology, Pusan National University School of Medicine, Busan, Korea.
  • 4Department of Pathology, Pusan National University School of Medicine, Busan, Korea.
  • 5Medical Research Institute, Pusan National University Hospital, Busan, Korea.

Abstract

BACKGROUND
In addition to Klinefelter's syndrome, microdeletion of Yq is the most common genetic cause of male infertility; 15% of azoospermic or 5-10% of oligozoospermic males have Yq deletions. We evaluated a Yq microdeletion kit (LG Life Sciences, Korea) for identifying microdeletions in the azoospermic factor (AZF) regions of the Yq.
METHODS
The kit was designed to amplify 3 regions of the AZF gene (AZFa, AZFb, and AZFc) using 15 sequence-tagged sites. We evaluated the preclinical performance of the kit. For clinical validation, 58 patients including 25 idiopathic azoospermic or oligozoospermic patients were examined.
RESULTS
We observed clear bands on electrophoresis of DNA, up to a DNA concentration of 3.12 ng/microliter; the known microdeletion regions of all 6 reference cell-lines (Coriell, USA) were accurately detected and no false positive/negative results showed with normal female (n=11) and fertile male (n=15) specimens. This kit could identify the same microdeletions in the common regions, similar to another commercial kit. Among the 58 male infertile patients, 7 (12.1%) had microdeletions of the Yq. Among the idiopathic azoospermic (n=22) and oligozoospermic (n=3) patients, 3 (12.0%) had microdeletions. Further, 2 of 21 varicocele patients (9.5%), 1 of 4 patients with testicular failure, and 1 patient with a 45,X/46,XY mosaic had microdeletions.
CONCLUSIONS
The kit was effective for detecting microdeletions of the Yq. We identified microdeletions in 12% of the infertile patients. This Y chromosome microdeletion detection kit is useful for screening Yq microdeletions in infertile patients.

Keyword

Infertility; Y chromosome; Azoospermic factor; Microdeletion

MeSH Terms

Azoospermia/genetics
*Chromosome Deletion
*Chromosomes, Human, Y
Electrophoresis, Agar Gel/methods
Female
Humans
Infertility, Male/genetics
Male
Oligospermia/genetics
Polymerase Chain Reaction/*methods
Reagent Kits, Diagnostic
Reproducibility of Results
Seminal Plasma Proteins/*genetics
Sensitivity and Specificity
Varicocele/genetics

Figure

  • Fig. 1. Multiplex PCR products of various concentrations of genomic DNA. The electrophoresis of PCR products revealed clear bands up to a concentration of 3.12 ng/μL of genomic DNA. Abbreviation: N, No DNA.

  • Fig. 2. Seven patients have microdeletions of the Y chromosome. Black squares indicate the sites of deletions. The first choice of STS markers recommended in European Academy of Andrology/European Molecular Genetics Quality Network guideline are marked with an asterix.

  • Fig. 3. The boxes on the gel image indicate microdeletions of Y chromosome of patient 4 (A) and patient 7 (B). Patient 4 has deletions of sY254, sY255, SPGY1, sY158, Y152, sY147, sY157, and sY242. Patient 7 has deletions of sY127, sY254, sY134, sY255, SPGY1, sY 158, sY152, sY147, sY157, sY242, sY130, and sY124.


Reference

1.Foresta C., Moro E., Ferlin A. Y chromosome microdeletions and alterations of spermatogenesis. Endocr Rev. 2001. 22:226–39.
Article
2.Korea Institute for Health and Social Affairs. http://www.kihasa.re.kr. (Accessed on April. 2010.
3.Dada R., Gupta NP., Kucheria K. Yq microdeletions—azoospermia factor candidate genes and spermatogenic arrest. J Biomol Tech. 2004. 15:176–83.
4.Tiepolo L., Zuffardi O. Localization of factors controlling spermatogenesis in the nonfluorescent portion of the human Y chromosome long arm. Hum Genet. 1976. 34:119–24.
Article
5.Vogt PH., Edelmann A., Kirsch S., Henegariu O., Hirschmann P., Kiesewetter F, et al. Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet. 1996. 5:933–43.
Article
6.Land JA., Evers JL. Risks and complications in assisted reproduction techniques: Report of an ESHRE consensus meeting. Hum Reprod. 2003. 18:455–7.
Article
7.Mitra A., Dada R., Kumar R., Gupta NP., Kucheria K., Gupta SK. Screening for Y-chromosome microdeletions in infertile Indian males: utility of simplified multiplex PCR. Indian J Med Res. 2008. 127:124–32.
8.Simoni M., Bakker E., Krausz C. EAA/EMQN best practice guidelines for molecular diagnosis of y-chromosomal microdeletions. State of the art 2004. Int J Androl. 2004. 27:240–9.
Article
9.Kuroda-Kawaguchi T., Skaletsky H., Brown LG., Minx PJ., Cordum HS., Waterston RH, et al. The AZFc region of the Y chromosome features massive palindromes and uniform recurrent deletions in infertile men. Nat Genet. 2001. 29:279–86.
Article
10.Repping S., Skaletsky H., Brown L., van Daalen SK., Korver CM., Pyntikova T, et al. Polymorphism for a 1.6-Mb deletion of the human Y chromosome persists through balance between recurrent mutation and haploid selection. Nat Genet. 2003. 35:247–51.
Article
11.Y chromosome microdeletion detection kit. Seoul, Korea: LG Life Sciences, Ltd.;2009. Sep. Package insert.
12.Simoni M., Bakker E., Eurlings MC., Matthijs G., Moro E., Muller CR, et al. Laboratory guidelines for molecular diagnosis of Y-chromosomal microdeletions. Int J Androl. 1999. 22:292–9.
Article
13.Ferlin A., Arredi B., Foresta C. Genetic causes of male infertility. Reprod Toxicol. 2006. 22:133–41.
Article
14.Cram DS., Osborne E., McLachlan RI. Y chromosome microdeletions: implications for assisted conception. Med J Aust. 2006. 185:433–4.
Article
15.Krausz C., Forti G., McElreavey K. The Y chromosome and male fertility and infertility. Int J Androl. 2003. 26:70–5.
16.Sadeghi-Nejad H., Farrokhi F. Genetics of azoospermia: current knowledge, clinical implications, and future directions. Part II: Y chromosome microdeletions. Urol J. 2007. 4:192–206.
17.Krausz C., Quintana-Murci L., McElreavey K. Prognostic value of Y deletion analysis: what is the clinical prognostic value of Y chromosome microdeletion analysis? Hum Reprod. 2000. 15:1431–4.
18.Ferlin A., Moro E., Garolla A., Foresta C. Human male infertility and Y chromosome deletions: role of the AZF-candidate genes DAZ, RBM and DFFRY. Hum Reprod. 1999. 14:1710–6.
Article
19.Hopps CV., Mielnik A., Goldstein M., Palermo GD., Rosenwaks Z., Schlegel PN. Detection of sperm in men with Y chromosome microdeletions of the AZFa, AZFb and AZFc regions. Hum Reprod. 2003. 18:1660–5.
Article
20.Peterlin B., Kunej T., Sinkovec J., Gligorievska N., Zorn B. Screening for Y chromosome microdeletions in 226 Slovenian subfertile men. Hum Reprod. 2002. 17:17–24.
Article
21.Oates RD., Silber S., Brown LG., Page DC. Clinical characterization of 42 oligospermic or azoospermic men with microdeletion of the AZFc region of the Y chromosome, and of 18 children conceived via ICSI. Hum Reprod. 2002. 17:2813–24.
Article
22.Bhasin S. Approach to the infertile man. J Clin Endocrinol Metab. 2007. 92:1995–2004.
Article
23.Enciso M., Muriel L., Fernandez JL., Goyanes V., Segrelles E., Marcos M, et al. Infertile men with varicocele show a high relative proportion of sperm cells with intense nuclear damage level, evidenced by the sperm chromatin dispersion test. J Androl. 2006. 27:106–11.
Article
24.Rao L., Babu A., Kanakavalli M., Padmalatha V., Singh A., Singh PK, et al. Chromosomal abnormalities and y chromosome microdeletions in infertile men with varicocele and idiopathic infertility of South Indian origin. J Androl. 2004. 25:147–53.
Article
25.Dada R., Kumar R., Shamsi MB., Sidhu T., Mitra A., Singh S, et al. Azoospermia factor deletions in varicocele cases with severe oligozoospermia. Indian J Med Sci. 2007. 61:505–10.
Article
Full Text Links
  • KJLM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr